Traders should monitor for future prospectus supplements that will disclose specific offering terms, which could lead to share dilution or capital infusion. The shelf registration provides flexibility but introduces uncertainty around future equity issuance.
Price Chart
Executive Summary
CITIUS ONCOLOGY, INC. (CTOR) has announced the effectiveness of its shelf registration statement (File No. 333-288656), allowing the company to issue unspecified securities from time to time. This creates a potential for future dilution, though no specific offering details such as size, pricing, or timing are disclosed.
Key Facts
- The SEC has declared effective a shelf registration statement (File No. 333-288656) for CITIUS ONCOLOGY, INC.
- The filing is a Form EFFECT, indicating the registration is now live.
- The company can now issue unspecified amounts of securities at unspecified prices and timing.
- No funds are being raised immediately; this is a forward-looking capital-raising mechanism.
- CitiUS Oncology is a life sciences company formerly known as TenX Keane Acquisition (name changed March 15, 2021).
Financial Impact
Not specified
Risk Factors
- Potential for future share dilution when offerings are executed under the shelf.
- Market perception of equity overhang could pressure the stock if investors anticipate near-term dilutive financing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-000698 |
| Document: 9999999995-26-000698-index.html | 9999999995-26-000698 |
| Document: 9999999995-26-000698.txt | 9999999995-26-000698 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $0.6000 | awaiting T+5 | — | $0.5960 (−0.67%) |
Oct 26, 2026 today | Press Release | $0.6072 | awaiting T+5 | — | $0.5960 (−1.84%) |
Oct 23, 2026 3d ago | 8-K | $0.5795 | awaiting T+5 | — | $0.5960 (−2.85%) |
Aug 12, 2026 10w ago | 8-K | $0.8115 $0.7525 | ▼ −7.27% | ▼ −6.83% | $0.5960 (−26.56%) |
Aug 5, 2026 11w ago | 8-K | $0.7850 $0.8115 | ▲ +3.38% | ▲ +3.03% | $0.5960 (−24.08%) |
Jun 8, 2026 20w ago | EFFECT | $0.7999 $0.6802 | ▲ +14.96% | ▲ +17.08% | $0.5960 (+25.49%) |
Jun 1, 2026 21w ago | 8-K | $0.7830 $0.7200 | ▼ −8.05% | ▼ −5.08% | $0.5960 (−23.88%) |
May 29, 2026 21w ago | S-3 | $0.7920 $0.7800 | ▲ +1.52% | ▼ −1.24% | $0.5960 (+24.75%) |
May 15, 2026 23w ago | 8-K | $0.8290 $0.8600 | ▲ +3.74% | ▲ +2.12% | $0.5960 (−28.11%) |
Mar 3, 2026 34w ago | EFFECT | $1.06 $1.01 | ▼ −5.19% | ▼ −4.71% | $0.5960 (−43.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers